The WACC of Atara Biotherapeutics Inc (ATRA) is 17.6%.
| Range | Selected | |
| Cost of equity | 7.70% - 12.30% | 10.00% |
| Tax rate | -% - -% | -% |
| Cost of debt | 7.00% - 49.90% | 28.45% |
| WACC | 7.4% - 27.7% | 17.6% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 0.84 | 1.32 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 7.70% | 12.30% |
| Tax rate | -% | -% |
| Debt/Equity ratio | 0.7 | 0.7 |
| Cost of debt | 7.00% | 49.90% |
| After-tax WACC | 7.4% | 27.7% |
| Selected WACC | 17.6% | |